Matilda buys NVO 46.17: Novo Nordisk A/S Receives Consensus Recommendation of âBuyâ from Analysts (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) has earned an average rating of âBuyâ from the seven ratings firms that are currently covering the stock, AnalystRatingsNetwork.com reports. Three investment analysts have rated the stock with a hold rating and four have ... ...
64 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home